logo-education
0370 270 6000

already registered?

Please sign in with your existing account details.

need to register?

Register to access exclusive content, sign up to receive our updates and personalise your experience on brownejacobson.com.

Privacy statement - Terms and conditions

Forgotten your password?

SEN reforms – not meeting needs?

15 December 2014

A survey by MENCAP has reported that over 80% of parents with a child with special educational needs (SEN) have indicated that they do not feel that their mainstream school is doing its best to allow the child to reach its potential. Nearly two-thirds of parents have indicated that they felt that their children received a poorer education than their peers who did not have SEN and the same proportion felt that their child was withdrawn from mainstream activities due to their disability. The report highlights concerns about teacher training on SEN being inadequate.

The report strikes at the key strands underpinning the recent SEN reforms – additional support being built on high quality teaching and every child being able to achieve their educational and other outcomes. Clearly, it is early days for the reforms and the report confirms the feeling that it will require a change in culture rather than just a change in the law to ensure the reforms can be seen as a success.

Related opinions

Does the move into Step 4 mean the ending of Covid-19 restrictions within schools?

With the Prime Ministers announcement that he intends for Step 4 to begin on 19 July, this will also bring an end to the restrictions currently in place on education settings.

View blog

Advocacy in Action: Female Genital Mutilation Protection Orders (FGMPO)

The issue of Female Genital Mutilation Protection Orders and the importance of education providers to act promptly.

View blog

Responsibilities towards students identifying as non-binary

Our top tips for supporting transgender and non-binary pupils.

View blog

Schools face scrutiny over Covid-19 vaccinations for children

On 4 June, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the use of the Pfizer/BioNTech Covid-19 vaccine for 12- to 15-year-olds.

View blog

Mailing list sign up

Select which mailings you would like to receive from us.

Sign up